Asia Pacific Diabetes Care Devices Market Latest Industry Trends, Swot Analysis And Demand From 2020 To 2027 – 3w Market News Reports

The growth of the market is driven by the factors such as, rapid technological advancements in diabetes care devices and increasing rate of obesity. However, the is likely to get impacted due to high cost of diabetes care devices and increasing prevalence of type 2 diabetes in the region.

China is expected to lead the market in the Asia Pacific region owing to highest rate of incidences for the type 2 diabetes and increasing awareness in the country. However, rise in the prevalence of the diabetes is likely to add novel opportunities in the forecast period. Therefore, considering the above mentioned factors the growth of the market in the country is likely to contribute largest share in the Asia Pacific region during the forecast period.

For Free Trial Subscription click at https://www.businessmarketinsights.com/request-trial/

Rest of Asia Pacific Diabetes Care Devices Market Revenue and Forecasts to 2027 ( US$ Mn)

ASIA PACIFIC DIABETES CARE DEVICES – MARKET SEGMENTATION

By Product

• Glucose Monitoring Devices

• • Glucometers
  • Lancets
  • Testing Strips
  • Other Glucose Monitoring Devices

• • Insulin Pens
  • Insulin Syringes
  • Insulin Pumps
  • Other Insulin Delivery Devices

By End User

• Hospitals & Clinics
• Homecare

By Geography

• Asia Pacific
  • China
  • Japan
  • India
  • South Korea
  • Australia
  • Rest of Asia Pacific

Company Profiles

• BD
• Novo Nordisk A/S
• B. Braun Melsungen AG
• Insulet Corporation
• Medtronic
• Tandem Diabetes Care, Inc.
• Eli Lilly and Company
• Dexcom, Inc.
• Terumo Corporation
• F. Hoffman-LA Roche Ltd.